Despite Setbacks, India Set For Strong Gains In Clinical Trials, Industry Lobby Says
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India is expected to see an unprecedented surge in the number of clinical trial projects during the year despite intermittent reports of informed consent violations and other good clinical practices concerns